Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer.

Guan XY, Sham JS, Tang TC, Fang Y, Huo KK, Yang JM.

Cancer Res. 2001 May 1;61(9):3806-9.

2.

Oncogenic role of eIF-5A2 in the development of ovarian cancer.

Guan XY, Fung JM, Ma NF, Lau SH, Tai LS, Xie D, Zhang Y, Hu L, Wu QL, Fang Y, Sham JS.

Cancer Res. 2004 Jun 15;64(12):4197-200.

3.

Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.

Yang GF, Xie D, Liu JH, Luo JH, Li LJ, Hua WF, Wu HM, Kung HF, Zeng YX, Guan XY.

Gynecol Oncol. 2009 Feb;112(2):314-8. doi: 10.1016/j.ygyno.2008.10.024.

PMID:
19054548
4.

Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma.

Xie D, Ma NF, Pan ZZ, Wu HX, Liu YD, Wu GQ, Kung HF, Guan XY.

Hum Pathol. 2008 Jan;39(1):80-6.

PMID:
17949776
5.

Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women.

Sham JS, Tang TC, Fang Y, Sun L, Qin LX, Wu QL, Xie D, Guan XY.

Cancer Genet Cytogenet. 2002 Feb;133(1):39-44.

PMID:
11890988
6.

Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma.

Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht GW, Meese E.

Hum Mol Genet. 1997 Jan;6(1):33-9.

7.

Translation initiation factor eIF-5A from Plasmodium falciparum.

Molitor IM, Knöbel S, Dang C, Spielmann T, Alléra A, König GM.

Mol Biochem Parasitol. 2004 Sep;137(1):65-74.

PMID:
15279952
8.

Identification of two novel Trichomonas vaginalis eif-5a genes.

Carvajal-Gamez B, Arroyo R, Lira R, López-Camarillo C, Alvarez-Sánchez ME.

Infect Genet Evol. 2010 Mar;10(2):284-91. doi: 10.1016/j.meegid.2009.12.008. Erratum in: Infect Genet Evol. 2010 Aug;10(6):804.

PMID:
20060503
9.

A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3.

Phillips NJ, Zeigler MR, Deaven LL.

Cancer Lett. 1996 Apr 19;102(1-2):85-90.

PMID:
8603384
10.

Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.

Nanjundan M, Nakayama Y, Cheng KW, Lahad J, Liu J, Lu K, Kuo WL, Smith-McCune K, Fishman D, Gray JW, Mills GB.

Cancer Res. 2007 Apr 1;67(7):3074-84.

11.
12.

The genomic structure encoding human initiation factor eIF-5A.

Koettnitz K, Kappel B, Baumruker T, Hauber J, Bevec D.

Gene. 1994 Jul 8;144(2):249-52.

PMID:
7545941
13.

Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer.

Redon R, Hussenet T, Bour G, Caulee K, Jost B, Muller D, Abecassis J, du Manoir S.

Cancer Res. 2002 Nov 1;62(21):6211-7.

15.
16.

Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder.

Luo JH, Hua WF, Rao HL, Liao YJ, Kung HF, Zeng YX, Guan XY, Chen W, Xie D.

Cancer Sci. 2009 May;100(5):896-902. doi: 10.1111/j.1349-7006.2009.01126.x.

17.

Overexpression of eIF-5A2 in mice causes accelerated organismal aging by increasing chromosome instability.

Chen M, Huang JD, Deng HK, Dong S, Deng W, Tsang SL, Huen MS, Chen L, Zan T, Zhu GX, Guan XY.

BMC Cancer. 2011 May 26;11:199. doi: 10.1186/1471-2407-11-199.

18.

Chromosome microdissection identifies cryptic sites of DNA sequence amplification in human ovarian carcinoma.

Guan XY, Cargile CB, Anzick SL, Thompson FH, Meltzer PS, Bittner ML, Taetle R, McGill JR, Trent JM.

Cancer Res. 1995 Aug 1;55(15):3380-5.

19.

Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.

Fejzo MS, Dering J, Ginther C, Anderson L, Ramos L, Walsh C, Karlan B, Slamon DJ.

Genes Chromosomes Cancer. 2008 Oct;47(10):873-83. doi: 10.1002/gcc.20592.

PMID:
18615678
20.

Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification.

Singh B, Gogineni SK, Sacks PG, Shaha AR, Shah JP, Stoffel A, Rao PH.

Cancer Res. 2001 Jun 1;61(11):4506-13.

Items per page

Supplemental Content

Support Center